Watertime, Author at PsyNews.com

Home Authors Posts by Watertime

135 POSTS 0 COMMENTS

atai Impact Establishes the atai Fellowship Fund in Psychedelic Neuroscience with...

Apeiron and Other Key Shareholders of atai Life Sciences Reinforce Support...

atai Life Sciences Has Been Selected for Addition to the NASDAQ...

atai Life Sciences to Participate in Upcoming January Investor Conference

atai Life Sciences Announces Successful Outcome of Phase 2a Biomarker Trial...

atai Life Sciences to Host Conference Call and Webcast to Discuss...

atai Life Sciences Reports Third Quarter 2021 Financial Results and Corporate...

atai Life Sciences Increases its Ownership Position in COMPASS Pathways

A Rundown of Colorado’s Natural Medicine Program

SXSW Psychedelics Conference 2025

Psychedelic Culture by Chacruna Institute

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Watertime

atai Impact Establishes the atai Fellowship Fund in Psychedelic Neuroscience with...

Apeiron and Other Key Shareholders of atai Life Sciences Reinforce Support...

atai Life Sciences Has Been Selected for Addition to the NASDAQ...

atai Life Sciences to Participate in Upcoming January Investor Conference

atai Life Sciences Announces Successful Outcome of Phase 2a Biomarker Trial...

atai Life Sciences to Host Conference Call and Webcast to Discuss...

atai Life Sciences Reports Third Quarter 2021 Financial Results and Corporate...

atai Life Sciences Increases its Ownership Position in COMPASS Pathways

June 2020 Newsletter

November 2020 Newsletter

EDITOR PICKS

A Rundown of Colorado’s Natural Medicine Program

SXSW Psychedelics Conference 2025

Psychedelic Culture by Chacruna Institute

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY